CRYSTALLINE VENLAFAXINE BASE AND NOVEL POLYMORPHS OF VENLAFAXINE HYDROCHLORIDE, PROCESSES FOR PREPARING THEREOF

Details for Australian Patent Application No. 2002365874 (hide)

Owner TEVA PHARMACEUTICAL INDUSTRIES LTD.

Inventors NISNEVICH, Gennady, A.; DOLITZKY, Ben-Zion; ARONHIME, Judith

Pub. Number AU-A-2002365874

PCT Number PCT/US02/37268

PCT Pub. Number WO2003/048082

Priority 10/000,428 30.11.01 US

Filing date 20 November 2002

Wipo publication date 17 June 2003

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 10/000,428 30.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002365874

29 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002365875-STENT DESIGNED FOR THE DELIVERY OF THERAPEAUTIC SUBSTANCE OR OTHER AGENTS

2002365873-MEDIA, FILTER ELEMENT USING CORRUGATED MEDIA SHEET, CORRUGATED SHEET, AND METHODS